4.5 Article

One-Pot Synthesis of Benzopyran-4-ones with Cancer Preventive and Therapeutic Potential

Journal

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
Volume 2016, Issue 5, Pages 965-975

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejoc.201501278

Keywords

Medicinal chemistry; Drug discovery; Anticancer agents; Oxygen heterocycles; Domino reactions; Michael addition; Antioxidants

Funding

  1. Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [UID/QUI/00062/2013, UID/CTM/50011/2013]
  2. European Union (EU)
  3. Quadro de Referencia Estrategico Nacional (QREN)
  4. Fundo Europeu de Desenvolvimento Regional (FEDER)
  5. Programa Operacional Factores de Competitividade (COMPETE)
  6. Associate Laboratory Centro de Investigacao em Materiais Ceramicos e Compositos - CICECO
  7. Portuguese National NMR Network (RNRMN)
  8. European Community [215009]
  9. General Directorate for Scientific Research and Technological Development-DGRSDT of Algeria
  10. FCT
  11. project New Strategies Applied to Neuropathological Disorders - QREN, Mais Centro-Programa Operacional Regional do Centro [CENTRO-07-ST24-FEDER-002034]
  12. EU, FEDER
  13. RSL, Luxembourg
  14. Fondation de Recherche Cancer et Sang
  15. Recherches Scientifiques Luxembourg association
  16. Een Haerz fur Kriibskrank Kanner association
  17. Action Lions Vaincre le Cancer association, Interreg IVA project Corena
  18. Televie Luxembourg
  19. Research Institute of Pharmaceutical Sciences by the NRF of the MEST of Korea [GCRC 2012-0001184]
  20. Brain Korea (BK21) PLUS program

Ask authors/readers for more resources

A one-pot synthesis of novel benzopyran-4-ones is described. In a tandem reaction, organobase-catalysed Michael addition of (RCOCH2COR2)-C-1 on chromone-3-carboxylic acid led to decarboxylation and pyran-4-one ring opening of the latter. This was followed by chromone- and/or chromanone ring closure of the resulting Michael adducts when R-1 is an ortho-hydroxyaryl group. Antioxidant testing of 14 derivatives identified strong antiradical properties of chromanones 3o-r (2.1-3.1 mu mol Trolox equiv./mu mol compound in the DPPH assay). Chromanones 3p and 3r and 2-styrylchromone 3k were also most potent in inducing the cytoprotective Keap1-Nrf2 signalling pathway in a reporter gene assay (fivefold induction at concentrations <3 mu M). Of the seven compounds evaluated for antiproliferative activities, 3k and 3r were the most active, inhibiting leukaemia K562 cell proliferation by 50% after 72 h at concentrations of 4.5 and 7.9 mu M, whereas normal peripheral blood mononuclear cells were not affected.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available